[go: up one dir, main page]

Benesch et al., 1974 - Google Patents

Chemical modifications that inhibit gelation of sickle hemoglobin

Benesch et al., 1974

View PDF
Document ID
1174948014083865435
Author
Benesch R
Benesch R
Yung S
Publication year
Publication venue
Proceedings of the National Academy of Sciences

External Links

Snippet

Substitution of the N-terminal amino groups with pyridoxal compounds inhibits gelation and increases the solubility of deoxy sickle hemoglobin (Hb S). Pyridoxylation of the α chains has considerably more effect than that of the β chains. The increase in minimum gelling …
Continue reading at www.pnas.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender

Similar Documents

Publication Publication Date Title
DE3851225T2 (en) BLOOD SET.
Benesch et al. The interaction of hemoglobin and its subunits with 2, 3-diphosphoglycerate.
Van Vliet et al. Changes in the haemoglobin types of sheep as a response to anaemia
EP0912197B1 (en) Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers
Tyuma et al. The preparation and properties of the isolated α and β subunits of hemoglobin A
Benesch et al. Chemical modifications that inhibit gelation of sickle hemoglobin
Sehgai et al. Preparation and in vitro characteristics of polymerized pyridoxylated hemoglobin
Nigen et al. Studies on the mechanism of action of cyanate in sickle cell disease: oxygen affinity and gelling properties of hemoglobin S carbamylated on specific chains
EP0176094B1 (en) Parenteral alimentation solution
NL8720283A (en) ACELLULAR SUBSTITUTION FOR RED BLOOD BODIES.
EP0265865A2 (en) Blood substitute
US20040023851A1 (en) Method for the porduction of artificial oxygen carriers from covalently cross linking haemoglobin with improved functional properties of haemoglobin by cross- linking in the presence of chemically non- reacting effectors of the oxygen affinity of the haemoglobin
Savla et al. Purification of lumbricus terrestris mega-hemoglobin for diverse oxygen therapeutic applications
Caldwell et al. The effect of oxygen, carbon dioxide, pH and cyanate on the binding of 2, 3-diphosphoglycerate to human hemoglobin
Norris et al. Preliminary crystallographic studies on human apolactoferrin in its native and deglycosylated forms
EP0528841B1 (en) A method for the preparation of pyridoxylated hemoglobin
D'Hondt et al. Oxygen-binding characteristics of three extra-cellular haemoglobins of Artemia salina
Benesch et al. 5'-deoxypyridoxal as a potential anti-sickling agent.
Fago et al. The hemoglobin system of the hagfish Myxine glutinosa: aggregation state and functional properties
Honig et al. Hemoglobin Abraham Lincoln, β32 (B14) Leucine→ Proline an unstable variant producing severe hemolytic disease
Furia et al. The effect of aspirin on sickling and oxygen affinity of erythrocytes
Freedman et al. Sickle hemoglobin gelation—inhibition by tris (hydroxymethyl) aminomethane and sugars
WO1999018979A1 (en) Storage-stable hemoglobin composition
de Furia et al. Oxygen affinity in hemoglobin Köln disease
Marti et al. Hb Altdorf α2β2 135 (H13) Ala→ Pro: A new electrophoretically silent unstable haemoglobin variant from Switzerland